ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours

Clicks: 3
ID: 325444
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #84 of 126 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 126 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Magnetic resonance imaging (MRI) is essential for post-treatment surveillance of patients with intracranial central nervous system (CNS) tumours. However, interpretation is often complicated due to post radiotherapy MRI abnormalities. Current literature demonstrates substantial heterogeneity in terminology and definitions used to describe these MRI abnormalities, limiting clinical decision-making and comparability across studies. To address this, an international multidisciplinary Delphi consensus was conducted within the Radiation Imaging and Neuro-Oncology Group (RING). Questionnaires were developed by the steering committee and distributed to experts in radiation oncology, neuroradiology, neuro-oncology, medical oncology, and neurosurgery. A three-round Delphi method was employed, with consensus defined as ≥ 75% agreement. Consensus was reached on the applicability and definitions with adoption of the term Treatment-Related Imaging Abnormality (TRIA). Clear definitions for potential and confirmed TRIA were established. Subcategorization based on imaging features all demonstrated high agreement. For consistent application of the framework minimal essential elements for MRI request forms were identified. The final consensus was endorsed by ESTRO, ESNR and EORTC. This Delphi consensus provides a standardized framework for MRI abnormalities following radiotherapy for intracranial CNS tumours. The framework aims to harmonize reporting, support clinical decision-making, and improve comparability in future neuro-oncology research. Central nervous system neoplasms - Radiotherapy - Magnetic resonance imaging – Delphi Technique - Treatment-Related Imaging Abnormality (TRIA)
Reference Key
openalex_W7203840104 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lieselotte Lauwens, Catharina M L Zegers, Alida A. Postma, Giuseppe Minniti, Claire Alapetite, Nicolaus Andratschke, Anna Berghoff, Malin Blomstrand, Thomas C. Booth, Antonella Castellano, Anthony J Chalmers, Jan Willem Dankbaar, Anna Falk Delgado, Johnny Duerinck, Felix Ehret, Sara Erridge, Enrico Franceschi, Julia Furtner, Norbert Galldiks, Semi Harrabi, Morten Høyer, Alberto Iannalfi, Tomas Kazda, E. Le Rhun, Ulrike Löbel, Giuseppe Lombardi, Carola Lütgendorf‐Caucig, Kshitij Mankad, Pierina Navarria, Maximilian Niyazi, Teresa Nunes, Albert Pons‐Escoda, Matthias Preusser, Ana Ramos, E. Razis, Erik Roelofs, Roberta Rudà, Julien Savatovsky, Juan M Sepúlveda, Pia C. Sundgren, Beate Timmermann, Esther G C Troost, Anouk van der Hoorn, Damien C. Weber, Michael Weller, Martin J van den Bent, Maarten Lambrecht, Marion Smits, Daniëlle B P Eekers
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag194
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.